Zomagen Biosciences
Technologiepark 94
9052 Gent
BE
Zomagen Biosciences
Foundation date
26/02/2020
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Small molecules
- #Supplier - Chemicals
- #Supplier - Distributors
- #Supplier - Instrumentation
- #Supplier - Laboratory consumables and reagents
- #Supplier - Laboratory equipment
- #Supplier - Medical devices
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Respiratory system
Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
Biotalys Appoints Laura J. Meyer to Board of Directors
1 day ago
Read more
-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
Jobs by Zomagen Biosciences
More jobsMore info?
Contact us
Ellen Telleir
Communication Coordinator